Brief: Vaccitech Reports Full-Year 2021 Financial Results And Recent Corporate Developments
March 25 (Reuters) - Vaccitech PLC VACC.O :
* VACCITECH REPORTS FULL-YEAR 2021 FINANCIAL RESULTS AND
RECENT
CORPORATE DEVELOPMENTS
* VACCITECH PLC - AS OF DECEMBER 31, 2021, CASH AND CASH
EQUIVALENTS WERE $214.1 MILLION, COMPARED TO $43.3 MILLION AS OF
DECEMBER 31, 2020
* VACCITECH PLC - COMPANY BELIEVES ITS CASH AND CASH
EQUIVALENTS
ARE SUFFICIENT TO FUND OPERATIONS INTO SECOND HALF OF 2024
Source text for Eikon: ID:nGNX5RZsMY
Further company coverage: VACC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Barinthus Biotherapeutics
See all newsBrief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics
Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026
Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease
Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments
Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing